Myles Minter

Stock Analyst at William Blair

(0)
# 4629
Out of 5,372 analysts
25
Total ratings
46.67%
Success rate
-13.77%
Average return
19 Stocks
Name Action PT Current % Upside Ratings Updated
VERV Verve Therapeutics
Downgrades: Market Perform
n/a
n/a n/a 1 Jun 17, 2025
VIGL Vigil Neuroscience
Downgrades: Market Perform
n/a
n/a n/a 1 May 22, 2025
IMUX Immunic
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Mar 25, 2025
CAMP Camp4 Therapeutics
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Nov 5, 2024
ARGX argenx
Upgrades: Outperform
n/a
n/a n/a 2 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Nov 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Oct 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
71
12.31 476.77% 1 Jul 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
n/a
n/a n/a 1 Jul 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
n/a
n/a n/a 1 Jul 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 May 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Mar 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 3 Sep 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Jun 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 2 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Sep 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Aug 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
116
124.84 -7.08% 1 Feb 24, 2020